Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
Chengdu Zenitar Biomedical Technology Co., Ltd
Prescient Therapeutics, Ltd.
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center